A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...

A York County business owner is sharing his story of hope after completing an innovative cancer treatment at WellSpan York Hospital. John Grim has been battling prostate cancer for nearly seven ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

Hello Health Rounds Readers! Today we feature a study that found seniors may be less vulnerable to bird flu than younger adults and children. We also report on studies that could lead to practice ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...